FDA Import Refusal SCS-5392221-9/11/1 — HAB Pharmaceuticals & Research Limited
The FDA refused shipment SCS-5392221-9/11/1 from HAB Pharmaceuticals & Research Limited (India) on May 19, 2021. The refused product falls under Drugs and Biologics — CARISOPRODOL (REGULATOR). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- May 19, 2021
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 65PCY57 CARISOPRODOL (REGULATOR)
- Charges
- 75